Drug Pricing Deals Expand Under Trump Administration
The Trump administration announced nine new drug pricing agreements, expanding a program that now includes 26 companies. These deals require participating firms to offer medications at prices comparable to those in peer countries and provide “most-favored nation” pricing to Medicaid programs. Health Secretary Robert F. Kennedy Jr. emphasized the pressure on officials like CMS Administrator Mehmet Oz to deliver results, according to a report by Daniel Payne and Elaine Chen.
Key Players and Financial Implications
While the exact impact on Medicare remains undisclosed, the agreements aim to reduce costs for U.S. patients. The White House highlighted commitments to bolster domestic manufacturing and medical stockpiles.
Read more about the drug pricing deals
Paxlovid Fails to Alleviate Long Covid Symptoms
A study led by Mass General Brigham found that Pfizer’s Paxlovid, effective against acute Covid-19, did not improve long Covid symptoms. The trial, published in Lancet Infectious Diseases, tested the drug on 15–25 days, with no significant benefits over a placebo. Co-principal investigator Lindsey Baden stated, “Treating viral persistence with this antiviral did not show clinical benefit.”
Implications for Long Covid Treatment
The findings challenge previous hopes for antiviral therapies in long Covid. The National Institutes of Health-funded study underscores the need for alternative approaches, as researchers explore other mechanisms to address lingering viral activity.
Explore the full study results
New Migraine Prevention Guidelines Highlight Treatment Advances
The American Headache Society and American Academy of Neurology updated their 2012 guidelines, recommending preventive treatment for patients with four or more migraines monthly. New therapies targeting the CGRP pathway are emphasized, with recommendations sorted by efficacy, tolerability, and safety. However, experts note affordability and access remain barriers.
Challenges in Implementing New Standards
While the guidelines reflect advancements, disparities in healthcare access could limit their impact. “Better outcomes depend on patients’ ability to seek and afford treatment,” said one expert.
Read more on the latest migraine guidelines
Dietitian Shortages Threaten Nutrition Initiatives
The Trump administration’s push for expanded nutrition programs faces obstacles as career opportunities for dietitians decline. Registered dietitian Jo-Ann Heslin warned that without systemic changes, the role of dietitians may vanish in 20 years. Rising educational costs and low reimbursement rates deter new professionals, complicating efforts to improve public health.
Impact on Public Health Goals
Learn about the dietitian crisis
Cannabis Edibles and Driving Impairment Study
A Canadian study found that cannabis edibles impaired driving abilities in a dose-dependent manner. Participants showed increased lane weaving, slower reaction times, and altered speeds. THC levels in high-dose groups remained below legal limits in Canada and 18 U.S. states, but the study highlights challenges in measuring impairment.
Legislative and Safety Considerations
The research underscores the need for clearer regulations around marijuana-impaired driving.
Read the JAMA Network Open study
NIH Grant Capping Proposal Sparks Mixed Reactions
The NIH’s proposal to limit grants per scientist has drawn 3,300 public comments. While 27% supported the cap, 40% opposed it, citing concerns about stifling innovation. The debate reflects broader tensions over resource allocation in a competitive research environment.
What’s Next for the Proposal?
Frequently Asked Questions
What is Paxlovid, and why is it important?
Paxlovid is an antiviral drug used to treat acute Covid-19. Recent studies show it does not help with long Covid symptoms, limiting its role in post-acute care.
How do the new migraine guidelines affect patients?
The guidelines recommend preventive treatment for frequent migraines, emphasizing new CGRP-targeting therapies. However, access and cost remain critical challenges.
Why are dietitians leaving the field?
Low pay, high education costs, and limited career growth are driving professionals away, threatening nutrition-focused health initiatives.
Did You Know?
The average THC concentration in high-dose cannabis edibles in the study was 3.4 ng/mL, below Canada’s legal limit of 5 ng/mL. This highlights the complexity of assessing impairment from marijuana.